Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
7.86
-0.63 (-7.42%)
At close: Sep 15, 2025, 4:00 PM EDT
8.00
+0.14 (1.78%)
After-hours: Sep 15, 2025, 5:06 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $326.74 million as of September 15, 2025. Its market cap has increased by 875.11% in one year.
Market Cap
326.74M
Enterprise Value
311.04M
1-Year Change
875.11%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $326.74M, a decrease of -10.69%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 352.93M | 416.65% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |